Dihydroxyphenylacetic acid in the treatment of Parkinsonism.
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage* / Q000009:adverse effects; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010648:Phenylacetates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011736:Pyridoxine / Q000008:administration & dosage
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D010648:Phenylacetates; D007980:Levodopa; D011736:Pyridoxine